PHARMACEUTICAL AGENTS
THE INVENTION PROVIDES A PHARMACEUTICAL COMPOSITION COMPRISING A PARTICULAR PHYSICAL FORM OF N-[4-[5-(CYCLOPENTYLOXY-CARBONYL)AMINO-1- METHYLINDOL-3-YL-METHYL]-3-METHOXYBENZOYL]-2-METHYL-BENZENESULPHONAMIDE AND POLYVINYLPYRROLIDONE. IT ALSO PROVIDES METHODS FOR PREPARING THIS PHYSICAL FORM, AND ANOT...
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | THE INVENTION PROVIDES A PHARMACEUTICAL COMPOSITION COMPRISING A PARTICULAR PHYSICAL FORM OF N-[4-[5-(CYCLOPENTYLOXY-CARBONYL)AMINO-1- METHYLINDOL-3-YL-METHYL]-3-METHOXYBENZOYL]-2-METHYL-BENZENESULPHONAMIDE AND POLYVINYLPYRROLIDONE. IT ALSO PROVIDES METHODS FOR PREPARING THIS PHYSICAL FORM, AND ANOTHER PHYSICAL FORM OF N-[4-[5-(CYCLOPENTYLOXYCARBONYL)AMINO-1-METHYLINDOL-3-YL-METHYL]-3-METHOXYBENZOYL]-2-METHYLBENZENESULPHONAMIDE USEFUL IN THE PREPARATION OF THE FIRST MENTIONED PHYSICAL FORM. THE COMPOSITIONS ARE USEFUL IN THE TREATMENT OF DISEASES IN WHICH LEUKOTRIENES ARE IMPLICATED, FOR EXAMPLE ASTHMA. |
---|